Autoimmune mechanisms of modulation of the activity of glutamate receptors in children with epilepsy and craniocerebral injury

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk

Volumn , Issue 12, 2008, Pages 44-51

  Pinelis, V G ^a   Sorokina, E G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 60849096993     PISSN: 08696047     EISSN: 24143545     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Aarli J. A., Tonder O. Immunological aspects of neurological diseases. Basel; New York; 1980.
2. Storch M. K. et al. Multiple sclerosis: in situ evidence for antibody and complement mediated demyelination. Ann. Neurol. 1998; 43: 465-471.
3. Archelos J. J., Hartung H.-P. Pathogenic role of autoantibodies in neurological diseases. Trends Neurosci. 2000; 23: 317-327.
4. Whitney K. D., McNamara J. O. GluR3 Autoantibodies destroy neuronal cells in a complement manner modulated by complement regulatory proteins. J. Neurosci. 2000; 20: 7307-7316.
5. Russian source
6. Dambinova S. A., Granstrem O. K., Tourov A. et al. Monitoring of brain spiking activity and autoantibodies to N-terminus domain of GluRl subunit of AMPA receptors in blood serum of rats with cobalt-induced epilepsy. J. Neurochem.1998; 71 (5): 2088-2093.
7. Russian source
8. Russian source
9. Poletaev A., Osipenko L. General network of natural autoantibodies as immunological homunculus (Immunculus). Autoimmun. Rev. 2003; 2: 264-271.
10. Kohler H., Paul S. Superantibody activities: new players in innate and adaptive immune responces. Immunol. Today 1998; 19: 221-227.
11. Kerschensteiner M., Gallmeier E., Behrens L. et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation. J. Exp. Med. 1999; 189: 865-870.
12. Ebadi M., BashirR. M., Heidrick M. L. et al. Neurotrophins and their receptors in nerve injury and repair. Neurochem. Int. 1997; 30: 347-374.
13. Mufson E. J., Kroin J. S., Sendera T. J. et al. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Progr. Neurobiol. 1999; 57: 451-484.
14. Geihl K. M., Tetzlaff W. BDNF and NT-3, but not NGF prevent axotomy-induced death of rat corticalspinal neuron in vivo. Eur. J. Neurosci. 1996; 8: 1167-1175.
15. Kerschensteiner M., Schwab M. E., Lichtman J. W., Misgeld T. In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. 2005; 11: 572-577.
16. Danysz W., Parsons C. Glycine and N-metlryl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol. Rev. 1998; 50 (4): 597-664.
17. Dingledine R, McBain C. J., McNamara I. O. Excitatory amino acid receptors in epilepsy. Trends Pharmacol. 1990; 11: 334-338.
18. Storm-Mathisen J., Leknes A. K., Bore A. T. et al. First visualization of Glutamate and GABA in neurons by immuno-cyto-chemistry. Nature 1983; 301: 517-520.
19. Dingledine R., Borges K, Bowie D., Traynetis S. F. The glutamate receptors ion channels. Pharmacol. Rev. 1999; 51 (1): 7-61.
20. Russian source
21. Miglio G., Vascaldi F., Lombardi G. Human T lymphocytes express N-methyl-D-aspartate receptors functionally active in controlling T cell activation. Biochem. Biophys. Res. Commun. 2005; 338 (4): 1875-1883.
22. Russian source
23. Michailovic L., Curtic D. Epileptiform activity evoked by intracerebral injection of antibrain antibodies. Brain Res. 1971; 32: 97-194.
24. Russian source
25. Russian source
26. Bassanini M., Baez A., Sotelo J. Immunoglobulins in epilepsy Neurol. Sci. 1982; 56 (2-3): 275-281.
27. Russian source
28. Arvin B., Neville L. F., Barone F. C, Feuerstein G. S. The role of inflammation and cytokines in brain injury. Neurosci. Biobehav. Rev. 1996; 20: 445-452.
29. Russian source
30. Choi D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1998; 1: 623-634.
31. Tirosh O., Sen C. K., Roy S., Packer L. Cellular and mitochondrial changes in glutamate-induced HT4 neuronal cell death. Neuroscience 2000; 97 (3): 531-541.
32. White B. S., Sullivan J. M., DeGracia D. J. et al. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci. 2000; 179: 1-33.
33. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 1999; 79 (4): 1431-1568.
34. Russian source
35. Russian source
36. Russian source
37. Hosford D. A., Crain B. J., Cao Z. et al. Increased AMPA-sensitive quisqualate receptor binding and reduced NMDA receptor binding in epileptic human hippocampus. J. Neurosci. 1991; 11 (2): 428-434.
38. Rogers S. W., Andrews P. I., GahringL. C. et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994; 265: 648-652.
39. Antozzi C., Granata T., Aurisano N. et al. Long-term selective IgG immuno-adsorption improvs Rassmussen's encephalitis. Neurology 1998; 51: 302-305.
40. Russian source
41. Russian source
42. Russian source
43. Russian source
44. Dambinova S. A., Khunteev G. A., Izykenova G. A. et al. Blood test detecting autoantibodies to N-methyl-D-aspartateneurore-ceptors for evaluation of patients with transient ischemic attack and stroke. Clin. Chem. 2003; 49 (10): 1752-1762.
45. Russian source
46. Russian source
47. Nellgard B., Wieloch T. Postishemic blocade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ishemia. J. Cereb. Blood Flow Metab. 1992; 12: 2-11.
48. Kalashnikova N. V., Motin V. G, Khodorov B. I. Contribution of AMPA- and MNDA receptors to use-dependent potentiation and inhibition of experimentally evoked epileptiform activity in rat hippocampal slices. 2005; 22 (1): 68-72.
49. Heurteawc C., Lauritzen I., Widmann C. et al. Glutamate-induced overexpression of NMDA-receptror messenger RNAs and protein triggered by activation of AMPA/kainate receptors in rat hippocampus following forebrain ischemia. Brain Res. 1994; 659: 67-74.
50. Russian source
51. PatelP. M., Drummond J. C, Cote D. J., Yaksh T. L. Differential temperature sensitivity of ischemia-induced glutamate release and eicosanoid production in rats. Brain Res. 1994; 650: 205-211.
52. Baker C. J., Bore A. J., Frazzini V. I. et al. Intraischemic hypothermia decreases the release of glutamate in the cores of permanent focal cerebral infarcts. Neurosurgery 1995; 36: 994-1001.
53. Zhao W., Richardson J. S., Mombourquette M. J. et.al. Neuroprotective effects of hypoterrnia and U-78517F in cerebral ischemia are due to reducing oxygen-based free radicals: an electron paramagnetic resonance study with gerbils. J. Neurosci. Res. 1996; 45: 282-288.
54. Busto R., Globus M. Y-T., Dietrich D. et al. Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain. Stroke 1989; 20: 904-910.
55. Russian source
56. Mayhan W. G. Nitric oxide donor-induced increase in permeability of the blood-brain barrier. Brain Res. 2000; 866: 101-108.
57. Russian source
58. Russian source
59. Russian source
60. Russian source
61. During M. J., Symes Ch. W., Lawlor P. A. et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 2000; 287 (5457): 1453-1460.
62. Russian source
63. Russian source
64. Russian source
65. Gonzales-Hernandez T., Garcia-Marin V., Perez-Delgado M. M. et al. Nitric oxide synthase expression in the cerebral cortex of patients with epilepsy. Epilepsia 2000; 41 (10): 1259-1268.
66. Itoh K., Watanabe M., Yoshikawa K. et al. Magnetic resonance and biochemical studies during pentylenetetrazole-kindling development: the relationship between nitric oxide, neuronal nitric oxide synthase and seizures. Neuroscience 2004; 129 (3): 757-766.
67. Kawakami Y., Monobe M., Kuvabara K. et al. A comparative study of nitric oxide, gluthatione, and gluthatione peroxidase activities in cerebrospinal fluid from children with convulsive diseases/children with aseptic meningitis. Brain Dev. 2006; 28 (4): 243-246.
68. Riazi K., Roshanpour M., Rafiei-Tabatabaei N. et al. The pro-convulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway. Br. J. Pharmacol. 2006; 147: 935-943.
69. Maksimovic M., Bokonjic D., Boskovic B. Nitric oxide (NO) and convulsions induced by pentylenetetrazole. Ann. N. Y. Acad. Sci. 2002; 962: 296-305.
70. Gahm C., Holmin S., T. Nitric oxide synthase expression after human brain contusiou Neurosurgery 2002; 50 (6): 1319-1326.
71. Cherian L., Chacko G., Goodman C., Robertson C. S. Neuro-protective effects of L-arginine administration after cortical impact injury in rats: response and time window J. Pharmacol. Exp. Ther 2003; 304 (2): 617-623.
72. Bin L., Hui-Ming G., Jiz-Yuh W. et at. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. N. Y. Acad. Sci. 2002; 962: 318-331.
73. Faden A. L Neuroprotection and traumatic brain injury: theoretical option or realistic proposition. Curr. Opin Neurol. 2002; 15: 707-712.
74. Gahm C., Danilov A., Holmin S. et al. Reduced neuronal injury after treatment with NG-nitro-L-arginine methyl ester (L-NAME) or 2-sulfo-phenyl-N-tert-butyl nitrone (S-PBN) following experimental brain contusion. Neurosurgery 2005; 57: 1272-1281.
75. Packer P., Beckman J. S., Liaudet L. Nitric oxide and perox-ynitrite in health and disease. Physiol. Rev. 2007; 87: 315-424.
76. Fedele E., Raiteri M. In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway. Progr. Neurobiol. 1999; 58: 89-120.
77. Russian source
78. Russian source
79. Russian source
80. Russian source